WuXi AppTec
http://www.wuxiapptec.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From WuXi AppTec
Supply Chain Derisking: The Case For US-India Partnering Amid China Clout
With just 14% of active pharmaceutical ingredients estimated to be made in the US and China’s overall dominance in the space, a new study points to the pressing need for the US to address bottlenecks in the supply chain and proposes a string of approaches to partner with India in its de-risking efforts.
Supply Chain Derisking: The Case For US-India Partnering Amid China Clout
With just 14% of active pharmaceutical ingredients estimated to be made in the US and China’s overall dominance in the space, a new study points to the pressing need for the US to address bottlenecks in the supply chain and proposes a string of approaches to partner with India in its de-risking efforts.
Syngene Chief: Large Cap Biopharma Taking China 'Rotation' More Seriously
A material shift in China derisking discussions by big biopharma against the backdrop of the proposed US BIOSECURE Bill is seen presenting opportunities for Syngene, though the tight US biotech funding environment dampened demand for the Indian CRDMO’s R&D services in Q4.
BIOSECURE: What’s Coming Next?
The potential impact of the BIOSECURE Act continues to spread as the Biden administration increases its focus on China. But with BIO's top lobbyist and the top House sponsor of the legislation now headed out the door, the future of the bill remains uncertain.
Company Information
- Industry
- Contract Research Organization-CRO
- Laboratory Testing Services
- Medical Devices
- Pharmaceuticals
- Services
-
Biotechnology
-
Drug Discovery Technologies
- ADMET
- Bioinformatics
-
Drug Discovery Technologies
- Other Names / Subsidiaries
-
- Crelux GmbH
- Faxian Therapeutics
- JW Biotechnology (Shanghai) Co., Ltd
- OXGENE
- ResearchPoint Global
- STA Pharmaceutical Co., Ltd.
- WuXi PharmaTech
- WuXi Merger Limited
- XenoBiotic Laboratories, Inc.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice